Blood-Brain Barrier Technologies Market – Global Industry Research Report at Transparency Market Research

Blood brain barriers are endothelial cells covering the capillaries of the brain. Some of the functions of these blood-brain barriers are:

Preventing pathogens (bacteria and viruses) and immune cells from entering the brain

Excluding and metabolizing neurotoxic compounds (drugs, antibodies and plasma proteins) and neurotransmitters from brain and blood

Safeguarding neurons’ ion balances

Browse Full Report with TOC: http://www.transparencymarketresearch.com/blood-brain-barrier-technologies.html

Rising global prevalence of Parkinson’s disease, cardiovascular diseases and rapidly aging world’s population are some of the drivers for the blood-brain barrier technologies market. Blood-brain barriers create CNS drug delivery problems and manufacturers are making rigorous investments in research and development to invent new drugs and drug delivery systems to amend CNS drug delivery problems. This holds the potential to open up new avenues for the market in terms of future growth opportunities.

Some of the major approaches in solving the blood-brain barrier (BBB) problems are lipidation, craniotomy-based drug delivery, BBB disruption, and cationic import peptides. The global BBB technologies market has five disease applications namely Parkinson’s disease, meningitis, Alzheimer’s disease, multiple sclerosis and encephalitis.

The North American BBB technologies market held the majority of the market share in 2011 and its market share is expected to reduce by slight margins by 2018 owing to the rapid economic developments in the Asian-Pacific region in countries such as India and China. The European BBB technologies market will exhibit relatively moderate CAGR from 2012 to 2018 and will maintain its second position in terms of market share throughout the forecast period.

Some of the key players of the blood-brain barrier technologies market include Allon Therapeutics, Inc., AngioChem Inc., Genzyme, CeNeRx BioPharma, Inc, Bioasis Technologies Inc., Ablynx...